Literature DB >> 28755029

Metastatic malignant PEComa of the leg with identification of ATRX mutation by next-generation sequencing.

Hussein Alnajar1, Arlen Brickman2, Lela Buckingham2, Leonidas D Arvanitis2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28755029     DOI: 10.1007/s00428-017-2208-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  13 in total

Review 1.  Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.

Authors:  Andrew L Folpe; Thomas Mentzel; Hans-Anton Lehr; Cyril Fisher; Bonnie L Balzer; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

Review 2.  Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.

Authors:  Rabindranath De La Fuente; Claudia Baumann; Maria M Viveiros
Journal:  Reproduction       Date:  2011-06-08       Impact factor: 3.906

3.  Altered telomeres in tumors with ATRX and DAXX mutations.

Authors:  Christopher M Heaphy; Roeland F de Wilde; Yuchen Jiao; Alison P Klein; Barish H Edil; Chanjuan Shi; Chetan Bettegowda; Fausto J Rodriguez; Charles G Eberhart; Sachidanand Hebbar; G Johan Offerhaus; Roger McLendon; B Ahmed Rasheed; Yiping He; Hai Yan; Darell D Bigner; Sueli Mieko Oba-Shinjo; Suely Kazue Nagahashi Marie; Gregory J Riggins; Kenneth W Kinzler; Bert Vogelstein; Ralph H Hruban; Anirban Maitra; Nickolas Papadopoulos; Alan K Meeker
Journal:  Science       Date:  2011-06-30       Impact factor: 47.728

4.  Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.

Authors:  Jen-Chieh Lee; Yung-Ming Jeng; Jau-Yu Liau; Jia-Huei Tsai; Hung-Han Hsu; Ching-Yao Yang
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

5.  Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.

Authors:  Rachel Litman Flynn; Kelli E Cox; Maya Jeitany; Hiroaki Wakimoto; Alysia R Bryll; Neil J Ganem; Francesca Bersani; Jose R Pineda; Mario L Suvà; Cyril H Benes; Daniel A Haber; Francois D Boussin; Lee Zou
Journal:  Science       Date:  2015-01-16       Impact factor: 47.728

6.  An unresectable malignant perivascular epithelioid cell tumor resistant to multiple combined chemotherapies: a unique case report.

Authors:  Junjie Peng; Baohua Yu; Jian Wang; Xiaonan Hong; Ye Xu; Sanjun Cai
Journal:  J Pediatr Hematol Oncol       Date:  2010-05       Impact factor: 1.289

Review 7.  ATRX: the case of a peculiar chromatin remodeler.

Authors:  Kajan Ratnakumar; Emily Bernstein
Journal:  Epigenetics       Date:  2012-12-18       Impact factor: 4.528

8.  Malignant PEComa: a case report with emphasis on clinical and morphological criteria.

Authors:  Federico Selvaggi; Domenico Risio; Roberta Claudi; Roberta Cianci; Domenico Angelucci; Daniela Pulcini; Alberto D'Aulerio; Margherita Legnini; Roberto Cotellese; Paolo Innocenti
Journal:  BMC Surg       Date:  2011-01-27       Impact factor: 2.102

Review 9.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

10.  Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.

Authors:  Giselle López; Nancy Ann Oberheim Bush; Mitchel S Berger; Arie Perry; David A Solomon
Journal:  Acta Neuropathol Commun       Date:  2017-05-15       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.